In this episode of Drive Time from Iantrek, Sara McLenighan speaks with Dr. Gagan Sawhney and Dr. Allison Dublin about where AlloFlo™ Uveo fits within the glaucoma treatment pathway. They discuss the gap between traditional MIGS and bleb-forming procedures, how their confidence evolved through early cases, and why patient selection is critical to success. For the field team, this episode offers practical guidance on supporting surgeons through the learning curve, reinforcing appropriate patient profiles, and helping build confidence with a controlled, bio-interventional approach.
Show Notes2:03 — Defining the treatment gap between MIGS and bleb-forming procedures
4:38 — How AlloFlo first emerged as a potential solution in their practices
8:37 — Early-case learnings around anesthesia, heme control, cleft creation, and visualization
13:57 — Identifying the ideal AlloFlo patient and helping surgeons start the right way
Credits
Host: Sara McLenighan, Vice President of Sales
Guest: Dr. Gagan Sawhney and Dr. Allison Dublin
Production: Schaefer Advertising Co.
For internal use only.